Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use. (Q37528454)

20 August 2017

1 reference

title

Cyclosporine A for neuroprotection: establishing dosing guidelines for safe and effective use. (English)

1 reference

20 August 2017

1 reference

Aaron M Cook

1

1 reference

20 August 2017

Justin Whitlow

series ordinal

2

1 reference

20 August 2017

Jimmi Hatton

series ordinal

3

1 reference

20 August 2017

Byron Young

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

Expert Opinion on Drug Safety

20 August 2017

1 reference

20 August 2017

8

1 reference

20 August 2017

4

1 reference

20 August 2017

411-419

1 reference

Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial

20 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

The Epidemiology of Traumatic Brain Injury: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Management of head trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

The Westmead Head Injury Project outcome in severe head injury. A comparative analysis of pre-hospital, clinical and CT variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Pharmacological treatment of traumatic brain injury: a review of agents in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

The immunophilin ligand FK506 attenuates axonal injury in an impact-acceleration model of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Administration of the immunophilin ligand FK506 differentially attenuates neurofilament compaction and impaired axonal transport in injured axons following diffuse traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Ventriculostomy-related infections: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Immune suppression and isolated severe head injury: a significant clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Dosing and safety of cyclosporine in patients with severe brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporine A and adverse effects on organs: histochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporin and organ specific toxicity: clinical aspects, pharmacogenetics and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Pharmacokinetic alterations after severe head injury. Clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Drug resistance in brain diseases and the role of drug efflux transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporin A disposition following acute traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Valproate therapy for prevention of posttraumatic seizures: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Effects of hypothermia on drug disposition, metabolism, and response: A focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporin pharmacokinetics in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

Cyclosporine kinetics in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

CYCLOSPORINE A PHARMACOKINETICS IN RHEUMATOID ARTHRITIS PATIENTS AFTER 6 MONTHS OF METHOTREXATE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903066742

10.1517/14740330903066742

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference